TP53 and Familial prostate cancer: The reason is that certain TAAs, such as p53, p16 and c-myc, which were used in the present mini-array approach, are associated with several types of cancer, including liver, colon, gastric, lung, ovarian and prostate cancer (18,20,22–25).